XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Operating Activities          
Net loss $ (123,997) $ (186,502) $ (223,766) $ (138,824)  
Adjustments to reconcile net loss to cash used in operating activities:          
Depreciation and amortization 36,888 49,225 77,207 99,334  
Stock-based compensation expense     25,743 53,732  
Deferred income taxes     (18,734) (8,600)  
Amortization of upfront incentive consideration     18,010 23,785  
Gain (loss) on extinguishment of debt (12,543) 0 (12,543) 3,533  
Amortization of debt discount and issuance costs     11,464 7,003  
Provision for expected credit losses     8,292 263  
(Gain) loss on investment fair value adjustment     (3,840) 29,520  
Other     (3,576) 3,363  
Dividends received from equity method investments     1,514 488  
Loss from discontinued operations (2) 284 401 150  
Gain on sale of assets and investments     0 (180,081)  
Changes in operating assets and liabilities:          
Accounts and other receivables     (101,815) (170,853)  
Prepaid expenses and other current assets     24,856 (7,658)  
Capitalized implementation costs     (4,368) (7,059)  
Upfront incentive consideration     (13,273) (6,593)  
Other assets     6,243 33,557  
Accrued compensation and related benefits     4,355 (31,370)  
Accounts payable and other accrued liabilities     72,479 73,736  
Deferred revenue including upfront solution fees     32,163 10,262  
Cash used in operating activities     (99,188) (212,312)  
Investing Activities          
Additions to property and equipment (30,080) (15,980) (48,190) (33,384)  
Acquisitions, net of cash acquired     (13,355) (6,986)  
Net proceeds from dispositions     0 392,268  
Purchase of investment in equity securities     0 (80,000)  
Cash (used in) provided by investing activities     (61,545) 271,898  
Financing Activities          
Payments on borrowings from lenders     (718,722) (629,479)  
Proceeds on borrowings from lenders     677,486 625,000  
Proceeds from borrowings under AR Facility     178,600 0  
Payments on borrowings under AR Facility     (48,600) 0  
Debt prepayment fees and issuance costs     (23,007) (9,747)  
Proceeds from sale of redeemable shares in subsidiary     16,000 0  
Dividends paid on preferred stock (5,000) (5,000) (10,693) (10,693)  
Net payment on the settlement of equity-based awards     (5,555) (15,330)  
Other financing activities     4,851 (159)  
Cash provided by (used in) financing activities     70,360 (40,408)  
Cash Flows from Discontinued Operations          
Cash provided by (used in) operating activities     80 (2,698)  
Cash provided by (used in) discontinued operations     80 (2,698)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash     1,554 (2,652)  
(Decrease) increase in cash, cash equivalents and restricted cash     (88,739) 13,828  
Cash, cash equivalents and restricted cash at beginning of period     815,923 999,391 $ 999,391
Cash, cash equivalents and restricted cash at end of period $ 727,184 $ 1,013,219 727,184 1,013,219 $ 815,923
Non-cash additions to property and equipment     $ 506 $ 2,286